Search results
Analyst Report: Bio-Techne Corp
Argus Research via Yahoo Finance· 2 days agoThrough its Protein Sciences business segment, Bio-Techne is one of the world's leading suppliers of proteins, such as cytokines and growth factors, immunoassays, antibodies, and reagents to ...
Scientists Intrigued by Bacteria That Turns Any Blood Into Universal Donor Type
Futurism via Yahoo News· 23 hours agoA team of researchers claims to have found a way to manipulate the enzymes present in blood...
'Terribly sorry, your blood may be contaminated'
BBC via Yahoo News· 4 days agoShe said: "The harder I pushed myself, I'd develop flu-like symptoms, my glands would swell and my joints ache." She received the letter in 1994 and...
Four state-of-the-art AI search engines for histopathology images may not be ready for clinical use
Medical Xpress· 3 days agoHelen Shang, a third-year internal medicine resident and incoming hematology-oncology fellow at the...
The fight goes on: WADA, doping, and the biological passport - part 1
Cyclingnews· 4 days agoOver the last 10 years, the sensitivity of doping and analysis has increased by a factor of 1,000,...
8 Signs You're Not Getting Enough Iron, Doctors Say
Best Life· 1 day agoIron is an essential mineral that your body uses to support growth and development, aid in the production of red blood cells, boost immune function, and...
Combined therapy makes headway for liver cancer
Medical Xpress· 2 days agoSimmons Comprehensive Cancer Center at UT Southwestern...
S2 Episode 1: Tumor Trash or Treasure? Liquid Biopsy for Colorectal Cancer
Medscape· 4 days agoFor more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify,...
Hereditary Amyloidosis: 5 Things to Know
Medscape· 6 days agoThe heterogeneity of hereditary amyloidosis can delay diagnosis and seriously affect prognosis and patient quality of life; these five things are need-to-know.
Q1 2024 IDEXX Laboratories Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 days agoConsumable gains were supported by 11% year-on-year growth in our global premium instrument installed base, reflecting gains across our Catalyst, Premium Hematology and SediVue ...
